HOOKIPA Pharma - Stock Price History | HOOK

Historical daily share price chart and data for HOOKIPA Pharma since 2021 adjusted for splits. The latest closing stock price for HOOKIPA Pharma as of October 26, 2021 is 4.93.
  • The all-time high HOOKIPA Pharma stock closing price was 19.51 on May 18, 2021.
  • The HOOKIPA Pharma 52-week high stock price is 20.00, which is 305.7% above the current share price.
  • The HOOKIPA Pharma 52-week low stock price is 4.86, which is 1.4% below the current share price.
  • The average HOOKIPA Pharma stock price for the last 52 weeks is 10.54.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
HOOKIPA Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 10.4240 12.1500 13.8000 5.9000 11.0900 -9.32%
2019 8.6857 14.0000 14.1500 6.1600 12.2300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.129B $0.020B
HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company. It is engaged in developing a class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform which is designed to reprogram the body's immune system. HOOKIPA Pharma Inc. is based in New York, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86